SE-ALTUVOCT®

ALTUVOCT® is a Bioengineered High-Sustained FVIII Replacement Therapy1,2

 

Altuvoct molecule
Altuvoct half life

Image adapted from Dargaud Y, et al. Haematologica. 2024 Aug 1;109(8):2436-2444.

References

EHL: extended half-life; Fc: constant fraction; FVIII: factor VIII; rFVIII: recombinant factor VIII; SHL: standard half-life; FvW: von Willebrand factor; AUC: area under the curve.

  1. von Drygalski A, et al. N Engl J Med 2023;388(4):310–318.
  2. Dargaud Y, et al. Haematologica. 2024 Aug 1;109(8):2436-2444.
  3. Seth Chhabra E, et al. Blood vol. 135,17 (2020): 1484-1496.
  4. Malec L et al. N Engl J Med 2024;391:235–46
  5. Sobi . ALTUVOCT SmPC, 2026
PP-34699
Other sites
expand_less